{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:44:24Z","timestamp":1774917864044,"version":"3.50.1"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T00:00:00Z","timestamp":1494460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Center for Health and Wellbeing, Princeton University"},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Princeton University (US), Department of Ecology and Evolutionary Biology"},{"name":"Hawai\u2019i Center for AIDS"},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008287","name":"Science and Technology Directorate","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008287","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0177195","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T18:11:49Z","timestamp":1494526309000},"page":"e0177195","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["The impact of HCV therapy in a high HIV-HCV prevalence population: A modeling study on people who inject drugs in Ho Chi Minh City, Vietnam"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2960-5084","authenticated-orcid":true,"given":"Ruthie B.","family":"Birger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thuy","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger D.","family":"Kouyos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan T.","family":"Grenfell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy B.","family":"Hallett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,5,11]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Hepatitis C Fact Sheet. World Health Organization; 2015. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/<\/ext-link>."},{"issue":"Suppl.(0)","key":"ref2","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jhep.2005.11.004","article-title":"Epidemiology of viral hepatitis and HIV co-infection","volume":"44","author":"M Alter","year":"2006","journal-title":"Journal of hepatology"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/QAD.0b013e3281053a0c","article-title":"Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours","volume":"21","author":"M Danta","year":"2007","journal-title":"Aids"},{"issue":"11","key":"ref4","first-page":"1473","article-title":"HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications","volume":"16","author":"M Andreoni","year":"2012","journal-title":"European review for medical and pharmacological sciences"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.epidem.2015.04.001","article-title":"Modeling the Effect of HIV Coinfection on Clearance and Sustained Virologic Response during Treatment for Hepatitis C Virus","volume":"12","author":"R Birger","year":"2015","journal-title":"Epidemics"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/QAI.0b013e3181a2539a","article-title":"The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis","volume":"51","author":"Ja Kwon","year":"2009","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"Suppl 2","key":"ref7","doi-asserted-by":"crossref","first-page":"ii23","DOI":"10.1136\/sti.2008.034660","article-title":"Modelling the transmission of HIV and HCV among injecting drug users in Rawalpindi, a low HCV prevalence setting in Pakistan","volume":"85","author":"P Vickerman","year":"2009","journal-title":"Sexually Transmitted Infections"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.epidem.2012.01.001","article-title":"Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users","volume":"4","author":"AS de Vos","year":"2012","journal-title":"Epidemics"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jhep.2010.08.029","article-title":"Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility","volume":"54","author":"NK Martin","year":"2011","journal-title":"Journal of Hepatology"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"e34548","DOI":"10.1371\/journal.pone.0034548","article-title":"Treatment of Hepatitis C as Prevention: A Modeling Case Study in Vietnam","volume":"7","author":"N Durier","year":"2012","journal-title":"PloS ONE"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/QAD.0b013e32835ca2dd","article-title":"The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis","volume":"27","author":"I Cremin","year":"2013","journal-title":"AIDS"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/cid\/cit687","article-title":"Modeling the Impact of Interventions Along the HIV Continuum of Care in Newark, New Jersey","volume":"58","author":"RB Birger","year":"2014","journal-title":"Clinical Infectious Diseases"},{"key":"ref13","article-title":"Evaluation of the epidemiological impact of harm reduction programs on HIV in Vietnam","year":"2011"},{"key":"ref14","article-title":"The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: Towards elimination of HIV transmission","author":"M Kato","year":"2013","journal-title":"Journal of acquired immune deficiency syndromes (1999)"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11901-013-0179-1","article-title":"Treatment of Hepatitis C in HIV Patients in the New Era of Direct-Acting Antivirals","volume":"12","author":"JV Fern\u00e1ndez-Montero","year":"2013","journal-title":"Current Hepatitis Reports"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40265-014-0179-7","article-title":"Sofosbuvir: first global approval","volume":"74","author":"GM Keating","year":"2014","journal-title":"Drugs"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nm.3538","article-title":"The price of good health","volume":"20","year":"2014","journal-title":"Nature medicine"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3949\/ccjm.81a.14010","article-title":"When are effective medications just too expensive?","volume":"81","author":"SJ Mehta","year":"2014","journal-title":"Cleveland Clinic journal of medicine"},{"key":"ref19","unstructured":"Fick M, Hirschler B. Gilead offers Egypt new hepatitis C drug at 99 percent discount; 2014. Available from: http:\/\/www.reuters.com\/article\/2014\/03\/21\/us-hepatitis-egypt-gilead-sciences-idUSBREA2K1VF20140321#GBr3kdauztVqKGe0.97<\/ext-link>."},{"key":"ref20","unstructured":"National Committee for AIDS Drugs and Prostitution Prevention and Control. Viet Nam AIDS Response Progress Report 2012. Ha Noi, Vietnam: UNAIDS; 2012."},{"key":"ref21","unstructured":"Statistical Office Ho Chi Minh City. 2015\u2014HCM City Statistics Office. Available from: http:\/\/www.pso.hochiminhcity.gov.vn\/web\/guest\/niengiamthongke-nam2015<\/ext-link>."},{"key":"ref22","first-page":"2007","article-title":"VIET NAM HIV\/AIDS ESTIMATES AND PROjECTIONS","year":"2012","journal-title":"VIET NAM HIV\/AIDS ESTIMATES AND PROjECTIONS"},{"key":"ref23","first-page":"457","article-title":"Public Health Aspects of HIV\/AIDS in Low and Middle Income Countries Epidemiology, Prevention and Care","author":"VM Quan","year":"2008"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1440-1746.1994.tb01265.x","article-title":"Hepatitis C and B virus infections in populations at low or high risk in Ho Chi Minh and Hanoi, Vietnam","volume":"9","author":"S Nakata","year":"1994","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s11524-009-9417-9","article-title":"Prevalence and Incidence of HCV Infection among Vietnam Heroin Users with Recent Onset of Injection","volume":"87","author":"MC Clatts","year":"2010","journal-title":"Journal of Urban Health: Bulletin of the New York Academy of Medicine"},{"key":"ref26","unstructured":"Phan HTT. Hepatitis C and human immunodeficiency virus infections in injecting drug users in drug treatment centers in Vietnam. University of Texas; 2009. Available from: http:\/\/digitalcommons.library.tmc.edu\/dissertations\/AAI3350199<\/ext-link>."},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/09540120802017610","article-title":"Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case\u2014control study","volume":"21","author":"V Quan","year":"2009","journal-title":"AIDS care"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Sereno L, Mesquita F, Kato M, Jacka D, Van Nguyen TT, Nguyen TN. Epidemiology, Responses, and Way Forward: The Silent Epidemic of Viral Hepatitis and HIV Coinfection in Vietnam. Journal of the International Association of Physicians in AIDS Care (JIAPAC). 2012.","DOI":"10.1177\/1545109712453939"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1053\/jhep.2001.29201","article-title":"The influence of human immunodeficiency virus coinfection on chronic Hepatitis C in injection drug users: A long-term retrospective cohort study","volume":"34","author":"V Di Martino","year":"2001","journal-title":"Hepatology"},{"key":"ref30","unstructured":"Vietnam Authority of HIV\/AIDS Control. Vietnam HIV and AIDS data. Ministry of Health; 2012. Available from: http:\/\/vaac.gov.vn\/Desktop.aspx\/Content\/Prevalence-data\/VIETNAM_HIV_and_AIDS_Overview_in_slides\/<\/ext-link>."},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.cgh.2010.08.024","article-title":"Liver disease in the HIV-infected individual","volume":"8","author":"JC Price","year":"2010","journal-title":"Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association"},{"issue":"15","key":"ref32","doi-asserted-by":"crossref","first-page":"7366","DOI":"10.1128\/JVI.00191-09","article-title":"Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes","volume":"83","author":"Y Rotman","year":"2009","journal-title":"Journal of virology"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.drugpo.2011.11.005","article-title":"Drug policy in Vietnam: A decade of change?","volume":"23","author":"T Vuong","year":"2012","journal-title":"International Journal of Drug Policy"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-7517-9-25","article-title":"Harm reduction and \u201cClean\u201d community: can Viet Nam have both?","volume":"9","author":"TH Khuat","year":"2012","journal-title":"Harm Reduction Journal"},{"issue":"S1","key":"ref35","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.drugpo.2014.11.011","article-title":"Compulsory drug detention centers in East and Southeast Asia","volume":"26","author":"A Kamarulzaman","year":"2015","journal-title":"International Journal of Drug Policy"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"e108939","DOI":"10.1371\/journal.pone.0108939","article-title":"Risk factors for delayed entrance into care after diagnosis among patients with late-stage HIV disease in southern Vietnam","volume":"9","author":"S Rangarajan","year":"2014","journal-title":"PLoS ONE"},{"key":"ref37","unstructured":"Wilson DP, Zhang L, Thein HH, Gray RT, Kwon Ja. Evaluation of the epidemiological impact of harm reduction programs on HIV in Vietnam. VAAC, UNAIDS, World Bank, UNSW, Partnership for Epidemic Analysis; 2011. Available from: https:\/\/kirby.unsw.edu.au\/sites\/default\/files\/hiv\/attachment\/FinalVietnamImpactEvaluationReport.pdf<\/ext-link>."},{"key":"ref38","article-title":"Effectiveness evaluation of the pilot program of opioid dependence with methadone in Hai phong and Ho Chi Minh cities (after 12 month treatment)","year":"2011"},{"issue":"9651","key":"ref39","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"BM Mathers","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/00126334-200405010-00011","article-title":"The natural history of HIV-1 infection in young Thai men after seroconversion","volume":"36","author":"R Rangsin","year":"2004","journal-title":"Journal of acquired immune deficiency syndromes"},{"key":"ref41","unstructured":"Do TN, Vietnam Authority of HIV\/AIDS Control. Access to ARV in Vietnam: Current situation and challenges. In: International AIDS Society Conference. Kuala Lumpur, Malaysia; 2013."},{"key":"ref42","article-title":"Results of the program evaluation of patients initiating antiretroviral therapy in two health facilities in Ho Chi Minh City, Viet Nam","year":"2010"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/hep.24489","article-title":"Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees","volume":"54","author":"H Barth","year":"2011","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S1473-3099(12)70010-5","article-title":"Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: Towards a vaccine","volume":"12","author":"J Grebely","year":"2012","journal-title":"The Lancet Infectious Diseases"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.22375","article-title":"Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression","volume":"48","author":"HH Thein","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"e0118304","DOI":"10.1371\/journal.pone.0118304","article-title":"Findings from integrated behavioral and biologic survey among males who inject drugs (MWID)\u2014Vietnam, 2009\u20132010: evidence of the need for an integrated response to HIV, hepatitis B virus, and hepatitis C virus","volume":"10","author":"P Nadol","year":"2015","journal-title":"PloS one"},{"key":"ref47","article-title":"Results from the HIV\/STI Integrated Biological and Behavioral Surveillance (IBBS) in Vietnam 2005\u20132006","year":"2006"},{"key":"ref48","article-title":"Results from the HIV\/STI Integrated Biological and Behavioral Surveillance (IBBS) in Vietnam 2009","year":"2009"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1360-0443.2010.03175.x","article-title":"Mortality and HIV transmission among male Vietnamese injection drug users","volume":"106","author":"VM Quan","year":"2010","journal-title":"Addiction"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1360-0443.2007.02122.x","article-title":"Drug abuse in Vietnam: a critical review of the literature and implications for future research","volume":"103","author":"VT Nguyen","year":"2008","journal-title":"Addiction"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-015-0075-9","article-title":"Impact of a methadone maintenance therapy pilot in Vietnam and its role in a scaled-up response","volume":"12","author":"TV Hoang","year":"2015","journal-title":"Harm Reduction Journal"},{"issue":"5","key":"ref52","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1086\/590501","article-title":"HIV-1 transmission, by stage of infection","volume":"198","author":"T Hollingsworth","year":"2008","journal-title":"Journal of Infectious Diseases"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/135965350601100103","article-title":"When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study","author":"M Badri","year":"2006","journal-title":"Antiviral therapy"},{"key":"ref54","article-title":"First-line Antiretroviral Therapy Outcomes in HIV-infected Adults in Ho Chi Minh City","author":"NT Chinh","year":"2010"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QCO.0b013e3283422e09","article-title":"Acute hepatitis C infection in HIV-positive patients","volume":"24","author":"M Vogel","year":"2011","journal-title":"Current opinion in infectious diseases"},{"issue":"20","key":"ref56","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMoa1214853","article-title":"Sofosbuvir for previously untreated chronic hepatitis C infection","volume":"368","author":"E Lawitz","year":"2013","journal-title":"The New England journal of medicine"},{"key":"ref57","article-title":"Pipeline oral HCV drugs and generic global access to DAAs: the need to mirror ARV programmes","author":"S Collins","year":"2013","journal-title":"Pipeline oral HCV drugs and generic global access to DAAs: the need to mirror ARV programmes"},{"issue":"4","key":"ref58","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nrgastro.2015.36","article-title":"Mixed HCV infection and reinfection in people who inject drugs\u2014impact on therapy","volume":"12","author":"EB Cunningham","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"ref59","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jhep.2016.01.029","article-title":"Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis","volume":"64","author":"GR Foster","year":"2016","journal-title":"Journal of Hepatology"},{"issue":"12","key":"ref60","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1097\/QAD.0b013e32833c11a5","article-title":"Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection","volume":"24","author":"TJW Van De Laar","year":"2010","journal-title":"AIDS"},{"issue":"Suppl 1","key":"ref61","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","article-title":"The global burden of hepatitis C","volume":"29","author":"D Lavanchy","year":"2009","journal-title":"Liver International: Official Journal of the International Association for the Study of the Liver"},{"issue":"7","key":"ref62","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/cid\/ciu012","article-title":"Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries","volume":"58","author":"A Hill","year":"2014","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"ref63","article-title":"Issuance of technical guideline on \u201cHCV Diagnosis and Treatment\u201d","year":"2016"},{"key":"ref64","unstructured":"World Health Organization. Global report on access to hepatitis C treatment; 2016. October."},{"key":"ref65","unstructured":"thuoctienloi.vn; 2014. Available from: http:\/\/www.thuoctienloi.vn\/thuoc-dieu-tri-viem-gan-c-ledvir.html<\/ext-link>."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0177195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T13:56:40Z","timestamp":1659016600000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0177195"}},"subtitle":[],"editor":[{"given":"Yury E","family":"Khudyakov","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,11]]},"references-count":65,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0177195","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,11]]}}}